Regenerative potential of Wharton's jelly‐derived mesenchymal stem cells: A new horizon of stem cell therapy

2020 ◽  
Vol 235 (12) ◽  
pp. 9230-9240 ◽  
Author(s):  
Hossein Abbaszadeh ◽  
Farzaneh Ghorbani ◽  
Mehdi Derakhshani ◽  
Ali Akbar Movassaghpour ◽  
Mehdi Yousefi ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Wharton’S Jelly ◽  
Wharton's Jelly

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

2009 ◽  
Vol 35 (2) ◽  
pp. 85-93 ◽  
Author(s):  
L. Vija ◽  
D. Farge ◽  
J.-F. Gautier ◽  
P. Vexiau ◽  
C. Dumitrache ◽  
...  
Keyword(s):  
Stem Cells ◽  
Type 1 Diabetes ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy

scholarly journals Journey of Mesenchymal Stem Cells for Homing: Strategies to Enhance Efficacy and Safety of Stem Cell Therapy

2012 ◽  
Vol 2012 ◽  
pp. 1-11 ◽  
Author(s):  
Sung Keun Kang ◽  
Il Seob Shin ◽  
Myung Soon Ko ◽  
Jung Youn Jo ◽  
Jeong Chan Ra
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Human Mesenchymal Stem Cells ◽  
Cellular Damage ◽  
Efficacy And Safety ◽  
Clinical Benefits

Human mesenchymal stem cells (MSCs) communicate with other cells in the human body and appear to “home” to areas of injury in response to signals of cellular damage, known as homing signals. This review of the state of current research on homing of MSCs suggests that favorable cellular conditions and thein vivoenvironment facilitate and are required for the migration of MSCs to the site of insult or injuryin vivo. We review the current understanding of MSC migration and discuss strategies for enhancing both the environmental and cellular conditions that give rise to effective homing of MSCs. This may allow MSCs to quickly find and migrate to injured tissues, where they may best exert clinical benefits resulting from improved homing and the presence of increased numbers of MSCs.

scholarly journals Human amnion-derived mesenchymal stem cells are a potential source for uterine stem cell therapy

2008 ◽  
Vol 41 (5) ◽  
pp. 709-725 ◽  
Author(s):  
K. Han ◽  
J. E. Lee ◽  
S. J. Kwon ◽  
S. Y. Park ◽  
S. H. Shim ◽  
...  
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Human Amnion ◽  
Potential Source

Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy

2014 ◽  
Vol 39 (1) ◽  
pp. 23-34 ◽  
Author(s):  
Hojjat Naderi-Meshkin ◽  
Ahmad Reza Bahrami ◽  
Hamid Reza Bidkhori ◽  
Mahdi Mirahmadi ◽  
Naghmeh Ahmadiankia
Keyword(s):  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy

Fetal bone marrow homing of donor mesenchymal stem cells after transamniotic stem cell therapy (TRASCET)

2018 ◽  
Vol 53 (1) ◽  
pp. 174-177 ◽  
Author(s):  
Hester F. Shieh ◽  
Azra Ahmed ◽  
Sarah A. Tracy ◽  
David Zurakowski ◽  
Dario O. Fauza
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Mesenchymal Stem Cells ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Fetal Bone
Sign in / Sign up

Export Citation Format

Share Document